当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析 - 现金流量表

凯赛生物

(688065)

  

流通市值:280.66亿  总市值:347.01亿
流通股本:5.83亿   总股本:7.21亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金564,116,3013,213,367,293.822,270,298,508.981,547,545,586.91
  收到的税费返还22,155,636.2945,619,840.6835,652,208.1313,277,594.43
  收到其他与经营活动有关的现金90,093,230.11379,418,388.05296,376,807.09251,607,396.39
  经营活动现金流入小计676,365,167.43,638,405,522.552,602,327,524.21,812,430,577.73
  购买商品、接受劳务支付的现金518,616,205.592,393,163,432.821,785,547,700.681,091,270,527.87
  支付给职工以及为职工支付的现金88,159,702.97293,181,079.26210,153,884.56142,444,627.79
  支付的各项税费60,974,599.04334,870,029.52254,279,960.47175,328,990.17
  支付其他与经营活动有关的现金29,609,273.71213,067,883.2779,252,756.2564,072,576.57
  经营活动现金流出小计697,359,781.313,234,282,424.872,329,234,301.961,473,116,722.4
  经营活动产生的现金流量净额平衡项目000-0.01
  经营活动产生的现金流量净额-20,994,613.91404,123,097.68273,093,222.24339,313,855.32
二、投资活动产生的现金流量:
  取得投资收益收到的现金-13,633,363.6--
  处置固定资产、无形资产和其他长期资产收回的现金净额-35,155,295.7735,109,714.2910,023,958.2
  收到的其他与投资活动有关的现金5,712,0003,503,590,096.82,308,152,943.99400,078,904.11
  投资活动现金流入小计5,712,0003,552,378,756.172,343,262,658.28410,102,862.31
  购建固定资产、无形资产和其他长期资产支付的现金295,347,599.73743,459,192.81546,099,764.78358,235,109.6
  投资支付的现金96,625,742.6625,500,00025,500,00025,500,000
  支付其他与投资活动有关的现金-3,509,302,096.83,214,564,276.561,500,000,000
  投资活动现金流出小计391,973,342.394,278,261,289.613,786,164,041.341,883,735,109.6
  投资活动产生的现金流量净额-386,261,342.39-725,882,533.44-1,442,901,383.06-1,473,632,247.29
三、筹资活动产生的现金流量:
  吸收投资收到的现金-5,967,224,993.635,967,224,993.635,967,224,993.63
  其中:子公司吸收少数股东投资收到的现金-52,500,00052,500,00052,500,000
  取得借款收到的现金634,683,745.09758,403,967.5515,727,619.61491,288,209.39
  收到其他与筹资活动有关的现金854,00029,359,500--
  筹资活动现金流入小计635,537,745.096,754,988,461.136,482,952,613.246,458,513,203.02
  偿还债务支付的现金10,500,0002,125,721,348.532,106,653,701.051,806,653,701.05
  分配股利、利润或偿付利息支付的现金2,984,968.76313,131,536.23303,675,702.4615,124,217.19
  支付其他与筹资活动有关的现金-946,253.97502,327.02502,327.02
  筹资活动现金流出小计13,484,968.762,439,799,138.732,410,831,730.531,822,280,245.26
  筹资活动产生的现金流量净额622,052,776.334,315,189,322.44,072,120,882.714,636,232,957.76
四、汇率变动对现金及现金等价物的影响-58,707,879.13-58,919,577.52-25,487,758.21-4,105,233.67
五、现金及现金等价物净增加额156,088,940.93,934,510,309.122,876,824,963.683,497,809,332.12
  加:期初现金及现金等价物余额9,120,475,022.245,185,964,713.125,185,964,713.125,185,964,713.12
  期末现金及现金等价物余额9,276,563,963.149,120,475,022.248,062,789,676.88,683,774,045.24
补充资料:
  净利润-529,502,308.11-284,191,771.38
  资产减值准备-135,700,535.02-57,703,425.03
  固定资产和投资性房地产折旧-295,072,759.25-147,637,368.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-295,072,759.25-147,637,368.92
  无形资产摊销-20,518,535.01-10,069,842.78
  长期待摊费用摊销-3,374,031.62-1,837,346.18
  处置固定资产、无形资产和其他长期资产的损失--6,708,160.46--5,186,013
  固定资产报废损失-28,990.91--
  公允价值变动损失----2,172,228.69
  财务费用-86,435,873.89-15,399,686.47
  投资损失--1,401,691.68-5,951,887.58
  递延所得税--67,750,463.49--28,638,050.83
  其中:递延所得税资产减少--67,750,463.49--28,963,885.14
    递延所得税负债增加---325,834.31
  存货的减少--395,288,462.56--39,253,099.97
  经营性应收项目的减少--382,674,198.3--159,953,837.79
  经营性应付项目的增加-174,785,663.87-41,731,786.3
  其他-798,637.95-3,099,205.14
  现金的期末余额-9,120,475,022.24-8,683,774,045.24
  减:现金的期初余额-5,185,964,713.12-5,185,964,713.12
  现金及现金等价物的净增加额-3,934,510,309.12-3,497,809,332.12
公告日期2026-04-302026-04-242025-10-312025-08-16
审计意见(境内)标准无保留意见
TOP↑